{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:43:14Z","timestamp":1760204594989,"version":"3.40.3"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[1996,2]]},"abstract":"<jats:p><jats:italic>Abstract<\/jats:italic>The objective of this study was to determine whether the calcium antagonist amlodipine could slow the progression of chronic renal disease. We examined the effects of amlodipine on kidney structure and function in two experimental models of hypertension. In the first study, adult, male Munich Wistar rats underwent uninephrectomy and were given weekly injections of desoxycorticosterone and 1% saline for drinking. Rats ingested normal chow or chow containing amlodipine for 8 weeks. The drug reduced systemic blood pressure, but glomerular filtration rate, kidney weight, proteinuria, and morphological evidence of glomerular injury were not affected. In the second study, male spontaneously hypertensive rats underwent uninephrectomy at 5 weeks of age and were followed for 6 months, during which they received no therapy or amlodipine. The drug dose was determined in preliminary studies to be the highest dose not associated with marked growth retardation. Again, although systemic blood pressure was significantly reduced by amlodipine, proteinuria and the prevalence of glomerulosclerosis were similar in amlodipine-treated and control spontaneously hypertensive rats. Micropuncture studies revealed that glomerular pressure remained elevated in amlodipine-treated spontaneously hypertensive rats. Kidney weight and glomerular volume were also similar in amlodipine-treated and control rats. Amlodipine also failed to inhibit platelet aggregation. Therefore, antihypertensive therapy with amlodipine fails to reduce glomerular pressure in spontaneously hypertensive rats as well as glomerular size and injury in spontaneously hypertension rats and desoxycorticosterone-salt hypertension. Although other dihydropyridine calcium antagonists have been found to reduce experimental glomerular injury, these data suggest that amlodipine may not prevent hypertensive nephrosclerosis.<\/jats:p>","DOI":"10.1161\/01.hyp.27.2.245","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T00:53:46Z","timestamp":1339462426000},"page":"245-250","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":39,"title":["Effects of Amlodipine on Glomerular Filtration, Growth, and Injury in Experimental Hypertension"],"prefix":"10.1161","volume":"27","author":[{"given":"Lance D.","family":"Dworkin","sequence":"first","affiliation":[{"name":"From the Department of Medicine, Brown University and Rhode Island Hospital, Providence (L.D.D., E.T.), and the Departments of Medicine (P.A.R.) and Pathology (J.C.H., H.F., R.I.L.), New York University Medical Center, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn","family":"Tolbert","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Brown University and Rhode Island Hospital, Providence (L.D.D., E.T.), and the Departments of Medicine (P.A.R.) and Pathology (J.C.H., H.F., R.I.L.), New York University Medical Center, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phoebe A.","family":"Recht","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Brown University and Rhode Island Hospital, Providence (L.D.D., E.T.), and the Departments of Medicine (P.A.R.) and Pathology (J.C.H., H.F., R.I.L.), New York University Medical Center, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan C.","family":"Hersch","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Brown University and Rhode Island Hospital, Providence (L.D.D., E.T.), and the Departments of Medicine (P.A.R.) and Pathology (J.C.H., H.F., R.I.L.), New York University Medical Center, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Feiner","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Brown University and Rhode Island Hospital, Providence (L.D.D., E.T.), and the Departments of Medicine (P.A.R.) and Pathology (J.C.H., H.F., R.I.L.), New York University Medical Center, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard I.","family":"Levin","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Brown University and Rhode Island Hospital, Providence (L.D.D., E.T.), and the Departments of Medicine (P.A.R.) and Pathology (J.C.H., H.F., R.I.L.), New York University Medical Center, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112528"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1989.54"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1991.141"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1992.309"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.294.6585.1443"},{"key":"e_1_3_2_6_2","first-page":"F598","volume":"259","year":"1990","unstructured":"Dworkin LD. Effect of nifedipine and enalapril on glomerular injury in rats with desoxycorticosterone-salt hypertension. Am J Physiol. 1990;259:F598-F604.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1987.6"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1989.289"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112377"},{"key":"e_1_3_2_10_2","first-page":"1448","volume":"3","year":"1984","unstructured":"Dworkin LD, Hostetter TH, Rennke HG, Brenner BM. Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension. J Clin Invest. 1984;3:1448-1461.","journal-title":"J Clin Invest"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1971.51.1.158"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110093"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajplegacy.1972.223.4.975"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(82)90490-9"},{"key":"e_1_3_2_15_2","first-page":"F85","volume":"241","year":"1981","unstructured":"Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol. 1981;241:F85-F93.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.17.3.288"},{"key":"e_1_3_2_17_2","first-page":"F425","volume":"254","year":"1988","unstructured":"Pelayo JC, Harris DCH, Shanley PF, Miller GJ, Schrier RW. Glomerular hemodynamic adaptations in remnant nephrons: effects of verapamil. Am J Physiol. 1988;254:F425-F431.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.114"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198806233182505"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1989.239"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1989.35"},{"key":"e_1_3_2_22_2","first-page":"F856","volume":"254","year":"1988","unstructured":"Meyer TW, Rennke HG. Progressive glomerular injury following limited infarction in the rat. Am J Physiol. 1988;254:F856-F862.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_23_2","first-page":"F1675","volume":"258","year":"1990","unstructured":"Benstein JA, Feiner HD, Parker M, Dworkin LD. Superiority of salt restriction over diuretics in reducing renal hypertrophy and injury in uninephrectomized SHR. Am J Physiol. 1990;258:F1675-F1681.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1992.222"},{"key":"e_1_3_2_25_2","first-page":"F1409","volume":"258","year":"1990","unstructured":"Daniels BS, Hostetter TH. Adverse effects of growth in the glomerular microcirculation. Am J Physiol. 1990;258:F1409-F1416.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1986.117"},{"key":"e_1_3_2_27_2","first-page":"F391","volume":"265","year":"1993","unstructured":"Bidani AK, Griffin KA, Picken M, Lansky DM. Continuous telemetric blood pressure monitoring and glomerular injury in the rat remnant kidney model. Am J Physiol. 1993;265:F391-F398.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"2A","DOI":"10.1016\/0002-9149(94)90268-2","volume":"73","year":"1994","unstructured":"Burges R, Moisey D. Unique pharmacologic properties of amlodipine. Am J Cardiol. 1994;73:2A-9A.","journal-title":"Am J Cardiol"},{"key":"e_1_3_2_29_2","first-page":"61","volume":"1","year":"1994","unstructured":"Oravcova J, Sojkova D, Fetkovska N, Trnovec T. Factors influencing isradipine and amlodipine binding to human plasma lipoproteins. Blood Press Suppl. 1994;1:61-64.","journal-title":"Blood Press Suppl"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199104000-00010"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0022-3565(25)38617-9","volume":"268","year":"1994","unstructured":"Cheng CP, Noda T, Nordlander M, Ohno M, Little WC. Comparison of effects of dihydropyridine calcium antagonists on left ventricular systolic and diastolic performance. J Pharmacol Exp Ther. 1994;268:1232-1241.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.4.5.681"},{"key":"e_1_3_2_33_2","unstructured":"Klahr S Heifets M Purderson ML. The influence of anticoagulation on the progression of experimental renal disease. In: Mitch WE ed. The Progressive Nature of Renal Disease. New York NY: Churchill Livingstone Inc; 1986:45-64."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(82)90287-0"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.1.193"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(83)90285-5"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.HYP.27.2.245","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T21:57:37Z","timestamp":1743371857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.HYP.27.2.245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1996,2]]}},"alternative-id":["10.1161\/01.HYP.27.2.245"],"URL":"https:\/\/doi.org\/10.1161\/01.hyp.27.2.245","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"type":"print","value":"0194-911X"},{"type":"electronic","value":"1524-4563"}],"subject":[],"published":{"date-parts":[[1996,2]]},"assertion":[{"value":"1994-09-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1995-10-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1996-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}